{"id":1364406,"date":"2026-10-25T02:31:18","date_gmt":"2026-10-25T02:31:18","guid":{"rendered":"https:\/\/www.europesays.com\/de\/1364406\/"},"modified":"2026-10-25T02:31:18","modified_gmt":"2026-10-25T02:31:18","slug":"melanom-neuartiger-krebsimpfstoff-senkte-rueckfallrisiko-der-patienten-um-42-prozent-welt","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/de\/1364406\/","title":{"rendered":"Melanom: Neuartiger Krebsimpfstoff senkte R\u00fcckfallrisiko der Patienten um 42 Prozent &#8211; WELT"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi4wFBVV95cUxQY2VKU3d2Tjh4OWtFSDVmMzF1dWF3MG9QVWwzNDJVQXJ0S3U1aEV6dFVyNFZ1NGVuclpVWU5BdExrNlBfS1lZYWdoSTNfdldYdGlpRXBiTXVaM1lheFlRaS1Tdnh1S05vUmpHVzd4aUxUTEhsQ2t6aTUyOWJxWjFoM2JPcFpBTDdsMzI4WUFJOFZIN09sYVkwZF9xaTFGTU9lbTVyemtBUC1ESEY1N0ZjN05mX1B4NzN1N3cwZzRsVjdRZXlFcDJaUEZBN0cxVm5QR2VoZElNdTNvOUVnY0pPd2I5NA?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Melanom: Neuartiger Krebsimpfstoff senkte R\u00fcckfallrisiko der Patienten um 42 Prozent<\/a>&nbsp;&nbsp;WELT<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMioAFBVV95cUxPelRJb0xpejA3YlFRY3FENGNfQ2dkOXlkU1lGX2o2RTF0TERYQ3d3NXgxOUprNXRESlBFY0RKdGpOZDk0UExybjNLX1JRWVhWb3UyblhGNWR2MWlVR2drempOVXBWTVVna1M3akhhUGFrRTJmU0dmaG52UUd4QmU0RGk3OEFBMGJ6SVcydUlaVUZ2QzRwMjBkMGlRUEl1S01i?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Hautkrebs: Erster mRNA-Krebsimpfstoff auf dem Weg zur Zulassung<\/a>&nbsp;&nbsp;Pharmazeutische Zeitung<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMilAFBVV95cUxPRjRVRWVCVFhBWUF1S2pGLTJvNFNpWW1ZcUhyRHRENDhQc2JOZEtEUk5kLXU4bmt0eDN2VzZaN21aLVlQWG50dDUtdll5eUlxd0sxRThjNjNzRFIyUmRuenhpU2ZzMk03eFljN2oyRUFsSGl5MU1kdUlmQkxmUVpScnQ5azN6UTNiOV9jRm53dHZNWEN6?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">mRNA-Impfstoff: Impfstoff senkt laut Studie R\u00fcckfall bei Hautkrebs um 42 Prozent<\/a>&nbsp;&nbsp;DIE ZEIT<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi3gFBVV95cUxNTWpHTUp5VkxERm9BMy1YZTF4d0w3TTBzbWhlekVZai1ZdWlRNnVTS09RRFIxOFBwSG9nXzFGZnhxNDdhdnhRaVpMWlBNMmUxNW9DNDJZM3I4OXNPaVBZbDQtOURYa28xRFFweW5zamtWcF9rQVNvZjYzelVqNG1iMzhtSHl0d01qZm53VUZidjVOMHRJbjVrYXd6YnRmelg1LXVtbjBTY25MS2tOM1JDZU5WTmdzREhQd2cxeEIzV1NlYlcwZ1lTN2NRY1YycVRfNHpBcnJXOVFCOUt5Mmc?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Moderna-Aktie: Warum sie trotz Krebsimpfungs-Erfolg 17,6 % verliert<\/a>&nbsp;&nbsp;BILD<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMirwFBVV95cUxQVGhYNGNBamlLd0pZVldYanhmRGlmT1RVVWtucHluM2kwMzh0WWhzbjRQcG9tYV9xdWF6MGZRWDA2b3ROTlNLRFUzMXA2RzBucVgtNWkzZXI1N0gzOExmMHBJWjBGYTRRTGZQY3c2Rl8zOXZXMjVVTGRGamdoZHprZ3VxTS1heUl1YmFjWWo1dWJxRXo0RWs1T0tBeGtYSi1idDBRVVlSeXJOQkNTTFBJ?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Impfung senkt Sterberisiko bei schwarzem Hautkrebs deutlich, aber&#8230;<\/a>&nbsp;&nbsp;WEB.DE<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Melanom: Neuartiger Krebsimpfstoff senkte R\u00fcckfallrisiko der Patienten um 42 Prozent&nbsp;&nbsp;WELT Hautkrebs: Erster mRNA-Krebsimpfstoff auf dem Weg zur Zulassung&nbsp;&nbsp;Pharmazeutische&hellip;\n","protected":false},"author":2,"featured_media":1364407,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[134],"tags":[3946,175,170,169,162,29,30,201004,91747,1080,82477,171,174,91714,20816,45,89309,173,172],"class_list":["post-1364406","post","type-post","status-publish","format-standard","has-post-thumbnail","category-unternehmen-maerkte","tag-biontech","tag-business","tag-companies","tag-companies-markets","tag-coronavirus","tag-deutschland","tag-germany","tag-hautkrebs-ks","tag-impfstoffe-ks","tag-krebs","tag-krebsvorsorge-ks","tag-markets","tag-maerkte","tag-moderna","tag-mrna-impfstoff","tag-texttospeech","tag-tumore-ks","tag-unternehmen","tag-unternehmen-maerkte"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@de\/117499205263646378","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/1364406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/comments?post=1364406"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/1364406\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media\/1364407"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media?parent=1364406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/categories?post=1364406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/tags?post=1364406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}